News

NYU Langone Medical Center Establishes Office of Therapeutics Alliances to Accelerate Drug Discovery
NYU Langone Medical Center has established a new drug discovery accelerator, the Office of Therapeutics Alliances (OTA). OTA is an innovative, nimble program that advances the discovery of novel therapeutic projects by combining the scientific strengths of NYU Langone investigators in dissecting disease pathways with the expertise of external professional drug discovery and development partners in the biopharma industry.

Element 117, first discovered by Lawrence Livermore scientists and international collaborators in 2010, is one step closer to being named.

University of Adelaide researchers have discovered that stem cells taken from teeth can grow to resemble brain cells, suggesting they could one day be used in the brain as a therapy for stroke.

As hydrogen fuel cell vehicles continue to roll out in increasing numbers, the infrastructure for fueling them must expand as well. To this end, a new project launched by the Energy Department and led by Sandia National Laboratories and the National Renewable Energy Laboratory (NREL) will work in support of H2USA, the public private partnership introduced in 2013 by the Energy Department and industry stakeholders to address the challenge of hydrogen infrastructure.















